drugset / Trial / NCT01461109
Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
NaSingle-groupOpen-label
Summary
The underlying goal of this study is to assess \[18F\] CFPyPB PET imaging as a tool to evaluate the activity of the GlyT1 receptors in the brain of Parkinson's Disease (PD) and Alzheimer Disease (AD) research participants.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-09
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CFPyPB | Unknown | 5 ug | — |
| Subject | CFPyPB | Unknown | 185 mbq | — |